Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit?

Ingber MS, Ibrahim IA, Killinger KA, Diokno AC, Peters KM.

Int Urogynecol J Pelvic Floor Dysfunct. 2009 Sep;20(9):1055-9. doi: 10.1007/s00192-009-0900-3. Epub 2009 May 14.

PMID:
19440647
2.

Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.

Musco S, Serati M, Lombardi G, Lumi E, Parisi AI, Del Popolo G, Finazzi Agrò E.

J Sex Med. 2016 Feb;13(2):238-42. doi: 10.1016/j.jsxm.2015.12.025. Epub 2016 Jan 20.

PMID:
26803455
3.

Changes in sexual functioning in women after neuromodulation for voiding dysfunction.

Yih JM, Killinger KA, Boura JA, Peters KM.

J Sex Med. 2013 Oct;10(10):2477-83. doi: 10.1111/jsm.12085. Epub 2013 Feb 27.

PMID:
23445354
4.

The effect of sacral neuromodulation on pudendal nerve function and female sexual function.

Parnell BA, Howard JF Jr, Geller EJ.

Neurourol Urodyn. 2015 Jun;34(5):456-60. doi: 10.1002/nau.22579. Epub 2014 Feb 24.

PMID:
24615871
5.

The effects of bilateral caudal epidural S2-4 neuromodulation on female sexual function.

Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodríguez LV.

Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):697-700. Epub 2007 Nov 30.

PMID:
18060341
6.

Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms.

Sacco E, D'Addessi A, Racioppi M, Pinto F, Totaro A, Bassi P.

Int J Gynaecol Obstet. 2012 May;117(2):168-72. doi: 10.1016/j.ijgo.2011.12.015. Epub 2012 Feb 22.

PMID:
22361478
7.

Psychosocial factors related to the use of InterStim® for the treatment of refractory overactive bladder.

Levin PJ, Siddiqui NY, Wu JM, Amundsen CL.

Female Pelvic Med Reconstr Surg. 2014 Sep-Oct;20(5):272-5. doi: 10.1097/SPV.0000000000000062.

PMID:
25181377
8.

Sacral neuromodulation and female sexuality.

Lombardi G, Finazzi Agrò E, Del Popolo G.

Int Urogynecol J. 2015 Dec;26(12):1751-7. doi: 10.1007/s00192-015-2708-7. Epub 2015 Apr 16. Review.

PMID:
25876714
9.

Effects of sacral neuromodulation on female sexual function.

Pauls RN, Marinkovic SP, Silva WA, Rooney CM, Kleeman SD, Karram MM.

Int Urogynecol J Pelvic Floor Dysfunct. 2007 Apr;18(4):391-5. Epub 2006 Jul 26.

PMID:
16868656
10.

Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.

Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW.

Neurourol Urodyn. 2007;26(1):19-28; discussion 36.

PMID:
17078071
11.

Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain.

Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodríguez LV.

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Apr;19(4):553-7. Epub 2007 Oct 10.

PMID:
17925994
12.

Effect of sacral neuromodulation on female sexual function and quality of life: Are they correlated?

Banakhar M, Gazwani Y, Kelini ME, Al-Shaiji T, Hassouna M.

Can Urol Assoc J. 2014 Nov;8(11-12):E762-7. doi: 10.5489/cuaj.2300.

13.

Medium-term experience of sacral neuromodulation by tined lead implantation.

Van Voskuilen AC, Oerlemans DJ, Weil EH, van den Hombergh U, van Kerrebroeck PE.

BJU Int. 2007 Jan;99(1):107-10. Epub 2006 Sep 6.

14.

Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.

Groenendijk PM, Lycklama à Nyeholt AA, Heesakkers JP, van Kerrebroeck PE, Hassouna MM, Gajewski JB, Cappellano F, Siegel SW, Fall M, Dijkema HE, Jonas U, van den Hombergh U; Sacral Nerve Stimulation Study Group.

BJU Int. 2008 Feb;101(3):325-9. Epub 2007 Dec 5.

15.

Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience.

Signorello D, Seitz CC, Berner L, Trenti E, Martini T, Galantini A, Lusuardi L, Lodde M, Pycha A.

J Sex Med. 2011 Apr;8(4):1147-55. doi: 10.1111/j.1743-6109.2010.02189.x. Epub 2011 Jan 26.

PMID:
21269397
16.

Sacral neuromodulation in urological indications: the Finnish experience.

Vaarala MH, Tammela TL, Perttilä I, Luukkonen P, Hellström P.

Scand J Urol Nephrol. 2011 Feb;45(1):46-51. doi: 10.3109/00365599.2010.523013. Epub 2010 Oct 21.

PMID:
20961268
17.

[Results of sacral posterior neuromodulation on voiding disorders and impact on sexuality based on a single-center study].

Ferhi K, Miaadi N, Tanneau Y, Leroi AM, Sibert L, Grise P.

Prog Urol. 2008 Mar;18(3):160-6. doi: 10.1016/j.purol.2007.11.003. Epub 2008 Apr 1. French.

PMID:
18472068
18.

Impact of treatment of overactive bladder with anticholinergics on sexual function.

Jha S.

Arch Gynecol Obstet. 2016 Feb;293(2):403-6. doi: 10.1007/s00404-015-3828-5. Epub 2015 Jul 30.

PMID:
26223187
19.

Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder.

Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Berg KC, Kan F, Irwin CP.

Neurourol Urodyn. 2015 Mar;34(3):224-30. doi: 10.1002/nau.22544. Epub 2014 Jan 10.

20.

Neuromodulation for Overactive Bladder Symptoms in Women Utilizing Either Motor or Sensory/Motor Provocation With a Minimum Nine-Year Follow-Up.

Marinkovic SP, Gillen LM, Marinkovic CM.

Neuromodulation. 2015 Aug;18(6):517-21; discussion 521. doi: 10.1111/ner.12291. Epub 2015 Apr 27.

PMID:
25919573

Supplemental Content

Support Center